PA
BIVV

Parallel Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Parallel Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-283
Closed -$15K – 2264
2017
Q4 		$15K Sell
283
-80
-22% -$4.38K ﹤0.01% 1143
2017
Q3 		$20K Sell
363
-58
-14% -$3.4K ﹤0.01% 1014
2017
Q2 		$26K Buy
421
+8
+2% +$456 ﹤0.01% 913
2017
Q1 		$23K Buy
+413
New +$20.3K ﹤0.01% 918

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Parallel Advisors's BIVV Position: Q1 2018 in Review

Parallel Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 283 shares — an estimated $15K sold.

Parallel Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $26K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Parallel Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Parallel Advisors sold 283 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $15K.
  • Parallel Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Parallel Advisors's Bioverativ Inc. Common Stock position peaked at $26K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Parallel Advisors's 13F filing for Q1 2018, filed 8 May 2018.